Literature DB >> 34931406

Urticarial vasculitis following mRNA anti-COVID-19 vaccine.

Gianluca Nazzaro1, Carlo Alberto Maronese1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34931406     DOI： 10.1111/dth.15282

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  5 in total

Review 1.  SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature review.

Authors:  Ayman Abdelmaksoud; Uwe Wollina; Selami Aykut Temiz; Abdulkarim Hasan
Journal:  Dermatol Ther       Date:  2022-03-25       Impact factor: 3.858

2.  A case of cutaneous arteritis after administration of mRNA coronavirus disease 2019 vaccine.

Authors:  Jun-Ichi Iwata; Yukiko Kanetsuna; Aiko Takano; Yoshihito Horiuchi
Journal:  Dermatol Ther       Date:  2022-06-15       Impact factor: 3.858

Review 3.  Urticarial vasculitis after COVID-19 vaccination: A case report and literature review.

Authors:  Hiroto Ono; Reimon Yamaguchi; Akira Shimizu
Journal:  Dermatol Ther       Date:  2022-06-14       Impact factor: 3.858

4.  Efficacy and safety of omalizumab therapy in urticaria vasculitis.

Authors:  Fiorella Petrelli; Daiana Giannini; Silvia Bilia; Isabella Del Corso; Valeria Rocchi; Paola Migliorini; Ilaria Puxeddu
Journal:  Front Allergy       Date:  2022-07-22

Review 5.  Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic.

Authors:  Carlo Alberto Maronese; Enrico Zelin; Gianluca Avallone; Chiara Moltrasio; Maurizio Romagnuolo; Simone Ribero; Pietro Quaglino; Angelo Valerio Marzano
Journal:  Front Med (Lausanne)       Date:  2022-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.